Tattenberg S, Shin J, Hohr C, Sung W
Radiother Oncol. 2024; 202:110603.
PMID: 39481608
PMC: 11663108.
DOI: 10.1016/j.radonc.2024.110603.
Nowicka Z, Kuna K, Laszczych M, Lazar-Poniatowska M, Sobocki B, Stawiski K
Phys Imaging Radiat Oncol. 2024; 30:100593.
PMID: 38912008
PMC: 11190719.
DOI: 10.1016/j.phro.2024.100593.
So Y, Kim Z, Cheong T, Chung M, Baek C, Son Y
Cancers (Basel). 2023; 15(14).
PMID: 37509202
PMC: 10377662.
DOI: 10.3390/cancers15143540.
Pierrard J, Van Ooteghem G, Van den Eynde M
Biomolecules. 2023; 13(4).
PMID: 37189436
PMC: 10136331.
DOI: 10.3390/biom13040689.
Yun J, Chung M, Baek C, Son Y, Ahn M, Oh D
Cancers (Basel). 2023; 15(4).
PMID: 36831590
PMC: 9954210.
DOI: 10.3390/cancers15041248.
Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors.
Laurent P, Morel D, Meziani L, Depil S, Deutsch E
Oncoimmunology. 2022; 12(1):2158013.
PMID: 36567802
PMC: 9788698.
DOI: 10.1080/2162402X.2022.2158013.
Immunity to Cryptosporidium: Lessons from Acquired and Primary Immunodeficiencies.
Cohn I, Henrickson S, Striepen B, Hunter C
J Immunol. 2022; 209(12):2261-2268.
PMID: 36469846
PMC: 9731348.
DOI: 10.4049/jimmunol.2200512.
Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review.
Ali M, Wani S, Masoodi M, Khan N, Shivakumar H, Osmani R
Clin Complement Med Pharmacol. 2022; 2(4):100041.
PMID: 36377228
PMC: 9035683.
DOI: 10.1016/j.ccmp.2022.100041.
Long-Term Effects of Radiation on Lymphocytes and Risk of Opportunistic Infections.
Swanson G, Hammonds K
Cureus. 2022; 14(7):e26887.
PMID: 35978733
PMC: 9375833.
DOI: 10.7759/cureus.26887.
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.
Chen F, Jin J, Hui T, Jing H, Zhang H, Nong Y
Front Oncol. 2022; 12:768956.
PMID: 35600350
PMC: 9118537.
DOI: 10.3389/fonc.2022.768956.
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617.
Jin J, Hu C, Xiao Y, Zhang H, Paulus R, Ellsworth S
Cancers (Basel). 2021; 13(24.
PMID: 34944813
PMC: 8699524.
DOI: 10.3390/cancers13246193.
Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer.
McLaughlin M, Alam M, Smith L, Ryckman J, Lin C, Baine M
PLoS One. 2020; 15(11):e0241505.
PMID: 33253196
PMC: 7703900.
DOI: 10.1371/journal.pone.0241505.
The Role of Modern Radiotherapy Technology in the Treatment of Esophageal Cancer.
Moon S, Suh Y
Korean J Thorac Cardiovasc Surg. 2020; 53(4):184-190.
PMID: 32793450
PMC: 7409878.
DOI: 10.5090/kjtcs.2020.53.4.184.
A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy.
Wang X, Wang P, Zhao Z, Mao Q, Yu J, Li M
Ther Adv Med Oncol. 2020; 12:1758835920926822.
PMID: 32518598
PMC: 7252357.
DOI: 10.1177/1758835920926822.
Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma.
Park S, Byun H, Seong J
Liver Cancer. 2019; 8(6):468-479.
PMID: 31799204
PMC: 6883451.
DOI: 10.1159/000500461.
Lymphopenia Is Associated with Gross Target Volumes and Fractions in Hepatocellular Carcinoma Patients Treated with External Beam Radiation Therapy and Also Indicates Worse Overall Survival.
Zhang H, Yang P, Jiang T, Zhang J, Jin X, Hu Y
Can J Gastroenterol Hepatol. 2019; 2019:9691067.
PMID: 31781521
PMC: 6855067.
DOI: 10.1155/2019/9691067.
Assessing the interactions between radiotherapy and antitumour immunity.
Grassberger C, Ellsworth S, Wilks M, Keane F, Loeffler J
Nat Rev Clin Oncol. 2019; 16(12):729-745.
PMID: 31243334
DOI: 10.1038/s41571-019-0238-9.
Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC.
Zhao Q, Chen G, Ye L, Shi S, Du S, Zeng Z
Radiat Oncol. 2019; 14(1):86.
PMID: 31133034
PMC: 6537222.
DOI: 10.1186/s13014-019-1287-z.
Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer.
Schad M, Dutta S, Muller D, Wijesooriya K, Showalter T
Adv Radiat Oncol. 2019; 4(2):323-330.
PMID: 31011677
PMC: 6460292.
DOI: 10.1016/j.adro.2019.01.005.
Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma.
Byun H, Kim N, Park S, Seong J
Strahlenther Onkol. 2019; 195(11):1007-1017.
PMID: 30989242
DOI: 10.1007/s00066-019-01462-5.
